"Die Universitätsklinik für Augenheilkunde des Inselspitals besteht seit 1834. Heute stehen wir unseren Patienten mit hochpräzisen Untersuchungs- und Operationstechniken und internationaler Kompetenz zur Seite. Im Notfall 24 Stunden und 7 Tage die Woche."

During the past decade, Universitatsklinik fur Augenheilkunde Inselspital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitatsklinik fur Augenheilkunde Inselspital" #1 sponsor was "University Hospital Inselspital, Berne" with 5 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "iSTAR Medical" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Kantonsspital Aarau" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitatsklinik fur Augenheilkunde Inselspital" #1 collaborator was "Fondation Bertarelli" with 1 trials as a collaborator, "Stiftung OPOS" with 1 trials as a collaborator, "University Hospital Inselspital, Berne" with 1 trials as a collaborator and "University of Bern" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Universitatsklinik fur Augenheilkunde Inselspital" are "Dry Eye Disease" (2 trials), "Geographic Atrophy" (2 trials), "Open Angle Glaucoma" (2 trials), "Age Related Maculopathy" (1 trials) and "Age-Related Maculopathies" (1 trials). Many other conditions were trialed in "Universitatsklinik fur Augenheilkunde Inselspital" in a lesser frequency.

Most popular intervention types in "Universitatsklinik fur Augenheilkunde Inselspital" are "Other" (6 trials), "Drug" (4 trials), "Device" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lampalizumab" (2 trials), "Ocular microbiome" (2 trials), "Abicipar Pegol" (1 trials), "Biometry with IOL-Master" (1 trials) and "Corneal tomography with Eyestar 900" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitatsklinik fur Augenheilkunde Inselspital" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Universitatsklinik fur Augenheilkunde Inselspital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Universitatsklinik fur Augenheilkunde Inselspital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Universitatsklinik fur Augenheilkunde Inselspital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".